Kriya Announces Publication of Preclinical Data for Its Investigational AAV-FGF21 Gene Therapy Demonstrating Durable Reversal of Liver Fibrosis

UF Startup Kriya Therapeutics, a biopharmaceutical company developing gene therapies to address common diseases affecting millions of people around the world, announced the publication of preclinical data for its investigational AAV-FGF21 gene therapy, generated by researchers at the Universitat Autonoma de Barcelona (UAB), Spain, in Molecular Therapy, the founding journal of the American Society of Gene & Cell Therapy (ASGCT).

Read more about Kriya Announces Publication of Preclinical Data for Its Investigational AAV-FGF21 Gene Therapy Demonstrating Durable Reversal of Liver Fibrosis.